Langenmayer, M.C.; Luelf-Averhoff, A.-T.; Marr, L.; Jany, S.; Freudenstein, A.; Adam-Neumair, S.; Tscherne, A.; Fux, R.; Rojas, J.J.; Blutke, A.;
et al. Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice. Pathogens 2023, 12, 867.
https://doi.org/10.3390/pathogens12070867
AMA Style
Langenmayer MC, Luelf-Averhoff A-T, Marr L, Jany S, Freudenstein A, Adam-Neumair S, Tscherne A, Fux R, Rojas JJ, Blutke A,
et al. Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice. Pathogens. 2023; 12(7):867.
https://doi.org/10.3390/pathogens12070867
Chicago/Turabian Style
Langenmayer, Martin C., Anna-Theresa Luelf-Averhoff, Lisa Marr, Sylvia Jany, Astrid Freudenstein, Silvia Adam-Neumair, Alina Tscherne, Robert Fux, Juan J. Rojas, Andreas Blutke,
and et al. 2023. "Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice" Pathogens 12, no. 7: 867.
https://doi.org/10.3390/pathogens12070867
APA Style
Langenmayer, M. C., Luelf-Averhoff, A.-T., Marr, L., Jany, S., Freudenstein, A., Adam-Neumair, S., Tscherne, A., Fux, R., Rojas, J. J., Blutke, A., Sutter, G., & Volz, A.
(2023). Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice. Pathogens, 12(7), 867.
https://doi.org/10.3390/pathogens12070867